Rolul inflamaţiei sistemice în evoluţia afecţiunilor cardiovasculare
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
770 7
Ultima descărcare din IBN:
2024-04-15 13:20
SM ISO690:2012
PANFILE, Elena. Rolul inflamaţiei sistemice în evoluţia afecţiunilor cardiovasculare. In: Curierul Medical, 2014, nr. 6(57), pp. 72-80. ISSN 1875-0666.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Curierul Medical
Numărul 6(57) / 2014 / ISSN 1875-0666

Rolul inflamaţiei sistemice în evoluţia afecţiunilor cardiovasculare

Pag. 72-80

Panfile Elena
 
IMSP Institutul de Cardiologie
 
 
Disponibil în IBN: 17 februarie 2015


Rezumat

Background: Growing clinic-experimental evidences suggest notable systemic inflammation implication in the pathogenesis of multiple cardiovascular diseases. This article is aimed at underlying the most important referred to inflammation mechanisms causing circulatory disorders and proven predictors of their diagnosis and prognosis. It has been established that crucial triggering factor of inflammatory response is the nuclear transcription factorkappaB whose activation leads to increased quantity and expression of a lot of inflammation mediators, like C reactive protein, cytokines (TNF-alpha, interleukins), chemokines (MCP-1) and intercellular adhesion molecules (selectins, integrins) which basically guide the sequestration of circulatory leukocytes. These mediators are responsible for inflammation sustaining and dissemination. On the other hand IL-10 is defined as a cytokine having anti-inflammatory action. The common effects of inflammation are endothelial dysfunction associated with NO synthesis impairment, oxidative stress boosting, extracellular matrix reorganization resulted from metalloproteinase activation, cell migration proliferation and apoptosis, neointima hyperplasia and plaque destabilization. Conclusions: Recent studies indicate the inflammation pathogenic value in the major adverse cardiovascular events development in patients undergone primary coronary revascularization by angioplasty, inclusive in-stent restenosis. Diabetes mellitus, smoking, dislipidemia, metabolic syndrome, hyperhomocysteinemia, arterial hypertension are main cardiovascular risk factors leading to inflammatory response augmentation.

Cuvinte-cheie
systemic inflammation, cardiovascular disorders.